Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (0.45%) to 9667.01, DAX +0.61% to 24028.14, CAC40 (0.09%) to 8114.74, STOXX 600 (0.01%) to 578.77

Dec 05 ,2025

  • Synopsis:

    • European equity markets closed mixed. Germany +0.7% outperformed and UK (0.5%) lagged. Follows broad strength in prior session. Autos, financial services and media were the best performing sectors whilst energy, banks and insurance were the worst performing.

    • Limited read-through for Europe from overseas markets. Market awaiting fresh catalysts with attention increasingly on next Wednesday's FOMC meeting. Market navigating another very busy week of AI news featuring more supply deals, chip production developments, and M&A/IPO activity. Sentiment surrounding European markets positive. Outlook for 2026 upbeat with sell-side anticipating healthy EPS growth and modest gains for regional equity markets.

    • On the macro data front, a string of supportive data from the euro area. Eurozone final Q3 GDP revised up to 0.3% versus prior 0.2%; German factory orders came in ahead of forecast; French industrial production beat; Italian retail sales ahead of forecast; only Spanish industrial production missed. Update from UK's Halifax showed slowdown in UK house prices on an annual basis, largely due to base effects.

    • Politico reported that ECB officials worried over Trump's Fed chair pick due to risk of inflationary spillover. German Chancellor Merz and French PM Lecornu survived critical budget votes. UK press focusing on potential shift in government position on Brexit after Deputy PM Lammy said rejoining customs union would boost growth.

    • On the corporate news flow front, at its CMD, Swiss Re (SREN.SW) announced that it targets FY26 net income of $4.5B vs FactSet $4.77B and will introduce sustainable annual buyback program in 2026 at $500M; still in the DACH region, SCHOTT Pharma (1SXP.GR) posted prelim FY numbers and - in the Nordics - Boliden (BOL.SS) issued its 2026 production guidance; in Belgium, UCB (UCB.BB) upgraded FY25 financial guidance amidst robust year to date performance.

    • Elsewhere, Unilever (ULVR.LN) announced that the demerger of its Ice Cream Business will complete on 6-Dec, Ocado Group (OCDO.LN) agreed one-off cash payment from Kroger of $350M to compensate Ocado following Kroger's recent decisions to optimise its CFC network and Ferd AS sold a 5.3% stake in Boozt Fashion (BOOZT.SS) for SEK105/sh.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Autos & Parts +1.49%, Financial Svcs +1.47%, Media +0.92%, Construct & Mtls +0.86%, Chemicals +0.61%, Technology +0.32%, Travel & Leisure +0.27%, Health Care +0.24%, Persnl & HHold Goods +0.13%, Ind Goods & Svcs +0.11%, Basic Resources +0.10%

      • Underperformers:

        • Oil & Gas (1.01%), Banks (0.69%), Insurance (0.66%), Utilities (0.58%), Real Estate (0.34%), Telecom (0.32%), Food & Beverage (0.24%), Retail (0.06%)

    • Macro:

      • Geopolitics

        • Putin and Modi speaking as they meet for trade and defence talks in India - BBC

        • Kremlin says Russia is encouraged by talks with US, ready to engage further - Reuters

      • Central Banks

        • ECB frets at prospect of Trump ally running US central bank - Politico

      • EU

        • EU leaders race to save Ukraine funding deal as Kyiv's cash runs low - The Guardian

      • UK

        • Lammy breaks ranks on Brexit - The Telegraph

        • UK's FCA Dismisses Calls for Market Abuse Inquiry Into Budget - Bloomberg

      • France

        • Xi woos Macron with sightseeing trip, but little in the way of deals - Reuters

      • Germany

        • Merz jets to Belgium to secure frozen Russian assets plan - FT

        • German Factory Orders Jump on 87% Surge in Big Items - Bloomberg

        • German parliament vote on pensions tests Merz's authority - Reuters

      • Italy

        • Meloni's Brothers of Italy picks fight with Bank of Italy over gold reserves - Politico

      • Netherlands

        • Dutch Pension Overhaul to Fuel Pivot From Long Bonds in EU - Bloomberg

    • Company news:

      • Notable Gainers

        • +8.6% IDEX.NO (IDEX Biometrics NOK3.29, +0.26) -- completes 7.3M private placement prices at NOK3/sh

        • +5.4% NESTE.FH (Neste €18.31, +0.94) -- BofA upgrade

        • +5.0% ALO.FP (Alstom €23.01, +1.09) -- Citi upgrade

        • +4.4% BUFAB.SS (Bufab SEK104.42, +4.42) -- Handelsbanken upgrade

        • +4.1% UBSG.SW (UBS Group CHF32.57, +1.28) -- report the Swiss government is preparing to water down part of UBS' capital rules

        • +3.6% ENSU.NO (Ensurge Micropower NOK0.83, +0.03) -- discloses subscription period for the subsequent offering

        • +3.2% SZG.GR (Salzgitter €37.60, +1.16)

        • +3.2% UCB.BB (UCB €247.50, +7.60) -- upgrades FY25 guidance

        • +2.8% VOLV.B.SS (Volvo SEK296.60, +8.10) -- Citi upgrade

        • +2.5% TKA.GR (ThyssenKrupp €9.43, +0.23)

        • +2.4% AFRY.SS (AFRY AB SEK156.60, +3.60) -- awarded new framework agreement with Regional Health Authority in Norway

        • +2.3% SAAB.B.SS (Saab SEK489.25, +11.00) -- BofA upgrade

        • +2.2% IWS.NO (Integrated Wind Solutions NOK46.70, +1.00) -- additional charter backlog

        • +2.1% KBX.GR (Knorr-Bremse €90.60, +1.90) -- Bank of America upgrade (we're told)

        • +1.1% OHLA.SM (Obrascon Huarte Lain €0.37, -0.00) -- announces resolution of the claim submitted in the litigation concerning the Sidra Hospital

      • Notable Decliners

        • -14.1% CANTA.SS (Cantargia SEK3.80, -0.63) -- updates on overall survival results from Phase 1B/2 TRIFOUR study

        • -6.7% BOOZT.SS (Boozt Fashion SEK105.60, -7.60) -- Ferd AS sells 5.3% stake in company for SEK105/share

        • -6.5% SREN.SW (Swiss Re CHF129.45, -9.05) -- CMD

        • -6.3% DMRE.GR (DEMIRE Deutsche Mittelstand Real Estate €0.44, -0.03)

        • -5.3% MONY.LN (MONY Group £1.82, -0.10) -- Morgan Stanley downgrade

        • -4.9% OEM.B.SS (OEM International SEK150.40, -7.80) -- Handelsbanken downgrade

        • -4.3% BYG.LN (Big Yellow Group £10.24, -0.46) -- terminates discussions with Blackstone

        • -4.1% GNFT.FP (GENFIT €4.65, -0.20)

        • -3.7% LATO.B.SS (Latour Investment SEK225.50, -8.60) -- initiated sell at ABG Sundal Collier

        • -3.1% FYB.GR (Formycon €24.95, -0.80)

        • -2.8% GTT.FP (Gaztransport & Technigaz €169.70, -4.80) -- Goldman Sachs downgrade

        • -2.6% BP.LN (BP £4.53, -0.12) -- BofA downgrade; BP reportedly in advanced discussions over sale of $8B Castrol unit to Stonepeak -- FT

        • -1.5% ENI.IM (Eni €16.10, -0.25) -- JPMorgan downgrade

    • EU companies reporting Monday:

      • Earnings:

        • DACHs: Stabilus (STM.GR), TKMS (TKMS.GR)

      • CMD/Events: Smith & Nephew (SN.LN), Surgical Science Sweden (SUS.SS), Helvetia Holding (HELN.SW) Business Update Call, UCB (UCB.BB) BofA R&D Call

  • Data:

    • Economics:

      • Germany Oct Factory Orders +1.5% m/m vs consensus +0.5% and prior revised +2.0% from +1.1%

      • UK Nov Halifax House Prices +0.7% y/y vs consensus +1.7% and prior +1.9%

      • Norway Oct Manufacturing Production (0.9%) m/m vs consensus +0.9% and prior revised (1.4%) from (1.7%)

      • Spain Oct Industrial Production +1.2% y/y vs consensus +2.1% and prior revised +1.5% from +1.7%

      • Italy Oct Retail Sales +1.3% y/y vs consensus +1.1% and prior revised +0.7% from +0.5%

      • Eurozone Q3 GDP +1.4% y/y vs 2nd estimate +1.4%

      • France

        • Oct Trade Balance (€3.9B) vs consensus (€6.8B) and prior revised (€6.4B) from (€6.6B)

        • Oct Industrial Production +0.2% m/m vs consensus (0.3%) and prior revised +0.7% from +0.8%

    • Markets:

      • WTI Crude (Jan 26): +$0.38 or +0.64% to $60.05

      • €-$ (0.0014) or (0.12%) to 1.1631

      • £-$ (0.0009) or (0.07%) to 1.3317

      • €-£ (0.0003) to 0.8736

      • S&P 500 +0.11%

      • Performance year-to-date

        • FTSE 100: +18.28%

        • DAX: +20.69%

        • CAC: +9.94%

        • MIB: +27.05%

        • Stoxx 600: +14.02%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE